Renal cell carcinoma

RENAL CELL CARCINOMA
  • Accounts of 3% of visceral cancers in USA and 85% of renal cancers in adults.
  • Age group is 6th & 7th decades with male predominance. Female to male ratio is 2:1
  • They are called hypernephromas because of their gross yellow colour & resemblance of tumor cells with clear cells of adrenal cortex.
  • Originate from tubular epithethial cells.
Epidemiology
  • Risk factors 
    • Tobacco- cigarette smoke doubles the incidence of Renal cell carcinoma.
    • Obesity
    • Hypertension
    • Unopposed estrogen therapy
    • Exposure to asbestos, petroleum products & heavy metals.
    • Chronic renal failure
    • Acquired cystic disease
  • Renal cancers are usually sporadic
  • Autosomal dominant familial cancers develop in younger individuals and they account for 4% of renal cell carcinoma. There tumors are seen associated with
    • Von –Hippel Lindau (VHL) syndrome
      • 1/2 to 2/3rd patients develop renal cysts and often bilateral & multiple renal cell carcinomas
      • VHL gene is implicated in the development of Renal cell carcinoma.
    • Hereditary familial clear cell carcinoma
      • Due to VHL gene abnormalities but do not show other manifestation of Von Hippel Lindau syndrome.
    • Hereditary papillary carcinoma:
      • Autosomal dominant form manifested by multiple bilateral tumors with papillary histology.
      • There tumors show mutations in the MET proto oncogene.
    • Herediatary leiomyomatosis and renal cell cancer syndrome
      • Autosomal dominant disease
      • Caused of FH gene mutation which expresses Fumarate hydratase
      • Characterised by uterine & cutaneous leiomyomata & an aggressive type papillary renal cell carcinoma.
      • It has increased propensiy for metastatic spread.
    • Birt –Hogg –Dube syndrome
      • Autosomal dominant inheritance pattern
      • Caused by BHD gene mutations which expresses folliculin
      • Syndrome is characterised by
        • Skin tumors
        • Pulmonary cysts
        • Renal tumors
Classification of Renal cell carcinoma depending upon the origin and cytogenetics
  • Clear cell carcinoma:
    • Common type (70 to 80% of RCC’s)
    • Origin – proximal tubular epithelial cells
    • 95% are sporadic (few familial)
    • Assocaited with VHL syndrome
    • There is deletion of sequence on chromosome 3 which has VHL gene (3P25.3).Second non deleted allele of VHL gene shows somatic mutation or hypermethylation induced inactivation.This indicates that VHL gene is tumor suppressor gene.
    • VHL gene encodes for a protein that forms a part of ubiquitin ligase complex involved in the degradation of proteins. Important target protein is Hypoxia Inclucible Factor-1(HIF -1). By inactivation of VHL, HIF-1 levels are increased which causes inappropriate expression of certain genes like VEGF (gene that promote angiogenesis),Insulin like growth factor-1. HIF also collaborates with oncogenic factor MYC to “reprogram” cellular metabolism which factors growth
  • Papillary carcinoma:
    • Account for 10% to 15% of Renal cell carcinomas
    • Origin-Distal convoluted tubular epithelial cells.
    • Occurs in both familial & sporadic forms
    • Cytogenetic abnormalities are trisomies 7 & 17 & loss of Y in male patients in sporadic form & trisomy 7 is familial form.
    • Gene involved is MET a proto oncogene present on chromosome 7.This gene encodes Tyrosine kinase receptor for Hepatocyte growth factor (HGF).
    • HGF mediates growth, cell mobility, invasion & morphogenetic differentiation.
    • These cancers are frequently multifocal.
  • Chromophobe carcinoma:
    • 5% of Renal cell carcinoma
    • Origin –  intercalated cells of collecting ducts
    • Cytogenetics –Multiple chromosome losses & extreme hypoploidy.
    • Excellent prognosis when compared to clear cell and papillary
  • XP11 translocation carcinoma
    • Genetically distinct subtype
    • Occurs in young patients
    • Cytogenetics- translocations of TFE3 gene located at Xp11.2 along with no of partner genes which results in increased expression of TFE3 transcript factor.
  • Collecting duct (Bellins duct) carcinoma-
    • 1% or less of renal cell carcinomas
    • Origin – collecting duct cells in medulla
    • Cytogenetics –chromosomal losses & deletions without distinct pattern.
MORPHOLOGY
  • RCC affects mostly poles of the kidney
  • Clear cell RCC
    • Occurs as solitary unilateral circumscribed tumor which is bright yellow to gray white in colour.
    • Yellow colour is due to lipid accumulation in tumor cells.
    • Cut section – variegated with hemorrhagic & necrotic areas.
    • Microscopy-
      • Tumor cells are arranged in trabecular or tubular or solid or cystic pattern.
      • Tumor cells are polygonal or rounded having abundant clear or granular cytoplasm containing glycogen and lipids
      • Delicate vascular branching may be present
      • Tumor may invade pelvic calyces & may extend into ureter.
      • Characteristic feature in RCC is, it invades renal vein, interior vena cave and grows as solid cords of cells and may also extend into the right  side of the heart
  • Papillary carcinoma
    • Can be multifocal and bilateral
    • Grossly they are large cystic & hemorrhagic
    • Microscopic:
      • Tumor cells are cuboidal to low columnar cells lining the papillae having fibrovascular core with foamy macrophages
      • Psammoma bodies may be present
      • Highly vascularised scant stroma is present.
  • Chromophobe RCC
    • Tumor cells have pale eosinophilic cytoplasm with perinuclear halo
    • Cells are arranged in solid sheets with perivascular arrangement of tumor cells
  • Collecting duct carcinoma
    • Tumor has irregular channels lined by highly atypical epithelium with hobnail pattern.

CLINICAL FEATURES
  • Clinical features in renal cell carcinoma are 
    • Costovertebral pain
    • Palpable mass
    • Haematuria
  • Most common presentation is haematuria
  • Tumor is usually silent until it reaches 10cms or more in size
  • Other generalized symptoms are fever, weakness and weight loss
  • Renal cell carcinoma produces syndromes associated with hormone production. They are 
    • Polycythemia
    • Hypercalcemia
    • Hypertension
    • Hepatic dysfunction
    •  Feminization or masculinization
    • Cushing syndrome
    • Eosinophilia
    • Leukamoid reaction
    • Amyloidosis
  • Metastasis occurs widely before the local symptoms and signs. Most common organs for metastasis are Lungs (50%), bones (33%), followed by regional lymphnodes, liver, adrenal and brain
  • Prognosis depends upon grading, staging and presence or absence of distant metastasis.
.
Reference 
  • Charles E. Alpers. The Kidney. In: Vinay Kumar, Abul K. Abbas, Nelson Fausto, Jon C. Aster. Robbins And Cotran Pathologic Basis of Disease. Eighth edition, 2011;Chapter 20: 905-970